DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in DiaMedica Therapeutics Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +7 vs. Q3 2024
- Shares held
- 6.73M
- +1.16M (+20.9%) vs. Q3 2024
- Total value
- $36.5M
- +$13.3M (+57.0%) vs. Q3 2024
- New holders
- 12
- 16 more added
- Sold out
- 5
- 5 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 88 | $87.8M |
| Q1 2026 | 99 | $79.2M |
| Q4 2025 | 92 | $96.0M |
| Q3 2025 | 78 | $82.8M |
| Q2 2025 | 58 | $34.2M |
| Q1 2025 | 57 | $28.5M |
| Q4 2024 | 45 | $36.5M |
| Q3 2024 | 40 | $23.3M |
| Q2 2024 | 32 | $14.9M |
| Q1 2024 | 32 | $12.7M |
| Q4 2023 | 38 | $10.9M |
| Q3 2023 | 36 | $11.0M |
| Q2 2023 | 32 | $15.1M |
| Q1 2023 | 25 | $3.93M |
| Q4 2022 | 28 | $3.99M |
| Q3 2022 | 26 | $3.14M |
| Q2 2022 | 28 | $7.42M |
| Q1 2022 | 34 | $10.0M |
| Q4 2021 | 39 | $14.9M |
| Q3 2021 | 34 | $11.2M |
| Q2 2021 | 43 | $16.9M |
| Q1 2021 | 41 | $52.1M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding DiaMedica Therapeutics Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cornerstone Planning Group LLC | 80 | $485 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 209 | $1.14K | 0.00% | −4−1.9% | Reduced |
| Royal Bank of Canada | 330 | $2.00K | 0.00% | −475−59.0% | Reduced |
| Legend Financial Advisors, Inc. | 1,000 | $5.43K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,055 | $5.73K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 1,070 | $5.80K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,769 | $9.61K | 0.00% | −10,970−86.1% | Reduced |
| US Bancorp | 4,335 | $23.5K | 0.00% | 00.0% | Unchanged |
| Massmutual Trust Co FSB | 4,824 | $26.2K | 0.00% | 00.0% | Unchanged |
| Magnolia Capital Advisors LLC | 10,160 | $55.2K | 0.01% | +160+1.6% | Added |
| Charles Schwab Investment Management Inc | 13,251 | $72.0K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 14,581 | $79.2K | 0.00% | +14,581 | New |
| Y-Intercept (Hong Kong) Ltd | 14,973 | $81.3K | 0.01% | +14,973 | New |
| Raymond James Financial Inc | 15,267 | $82.9K | 0.00% | +15,267 | New |
| Bank of Montreal | 15,560 | $84.5K | 0.00% | +15,560 | New |
| Citadel Advisors LLC | 16,113 | $87.5K | 0.00% | +4,282+36.2% | Added |
| BNP Paribas Arbitrage, SA | 16,800 | $91.2K | 0.00% | +300+1.8% | Added |
| Stonebridge Capital Advisors LLC | 17,500 | $95.0K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 19,339 | $105.0K | 0.00% | +2,380+14.0% | Added |
| Pensionmark Financial Group, LLC | 21,915 | $119.0K | 0.00% | +21,915 | New |
| Omers Administration Corp | 22,500 | $122.2K | 0.00% | +22,500 | New |
| Jefferies Financial Group Inc. | 26,000 | $141.2K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 26,097 | $141.7K | 0.00% | +26,097 | New |
| Meridian Wealth Management, LLC | 27,216 | $147.8K | 0.01% | +27,216 | New |
| Barclays PLC | 27,726 | $150.6K | 0.00% | +27,726 | New |
| Catalyst Financial Partners LLC | 38,457 | $208.8K | 0.04% | 00.0% | Unchanged |
| Citigroup Inc | 38,474 | $208.9K | 0.00% | +16,377+74.1% | Added |
| Jane Street Group, LLC | 42,212 | $229.2K | 0.00% | +42,212 | New |
| Goldman Sachs Group Inc | 68,948 | $374.4K | 0.00% | +68,948 | New |
| Ronald Blue Trust, Inc. | 69,122 | $375.3K | 0.00% | +24,875+56.2% | Added |
| 683 Capital Management, LLC | 76,116 | $413.3K | 0.04% | +76,116 | New |
| Millennium Management LLC | 84,829 | $460.6K | 0.00% | +51,139+151.8% | Added |
| State Street Corp | 85,029 | $461.7K | 0.00% | +16,300+23.7% | Added |
| Morgan Stanley | 87,429 | $474.7K | 0.00% | −22,587−20.5% | Reduced |
| Qube Research & Technologies Ltd | 94,769 | $514.6K | 0.00% | +42,680+81.9% | Added |
| BlackRock, Inc. | 107,880 | $585.8K | 0.00% | +90+0.1% | Added |
| LPL Financial LLC | 152,000 | $825.4K | 0.00% | +11,500+8.2% | Added |
| Northern Trust Corp | 180,192 | $978.4K | 0.00% | +59,902+49.8% | Added |
| Geode Capital Management, LLC | 305,751 | $1.66M | 0.00% | −1,207−0.4% | Reduced |
| Susquehanna International Group, LLP | 374,845 | $2.04M | 0.00% | +273,395+269.5% | Added |
| Bleichroeder LP | 382,317 | $2.08M | 0.52% | 00.0% | Unchanged |
| Paragon Associates & Paragon Associates II Joint Venture | 514,784 | $2.80M | 6.46% | +32,170+6.7% | Added |
| First Manhattan Co | 839,081 | $4.56M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,242,107 | $6.74M | 0.00% | +193,078+18.4% | Added |
| Cooperman Leon G | 1,625,000 | $8.82M | 0.33% | +113,261+7.5% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −9,498−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,662−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −3,263−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,118−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |
| Naples Money Management LLC | – | – | – | – | Not filed |